C08CA01 - amlodipine : Belongs to the class of dihydropyridine derivative selective calcium-channel blockers with mainly vascular effects. Used in the treatment of cardiovascular diseases.
C08CA01 - amlodipine : Belongs to the class of dihydropyridine derivative selective calcium-channel blockers with mainly vascular effects. Used in the treatment of cardiovascular diseases.
C08CA04 - nicardipine : Belongs to the class of dihydropyridine derivative selective calcium-channel blockers with mainly vascular effects. Used in the treatment of cardiovascular diseases.
R01BA53, R06AB51 - phenylephrine, combinations, brompheniramine, combinations : Belongs to the class of systemic sympathomimetic preparations used as nasal decongestants., Belongs to the class of substituted alkylamines used as systemic antihistamines.
A03AA07 - dicycloverine : Belongs to the class of synthetic anticholinergics, esters with tertiary amino group. Used in the treatment of functional bowel disorders.
A03AA07 - dicycloverine : Belongs to the class of synthetic anticholinergics, esters with tertiary amino group. Used in the treatment of functional bowel disorders.
R03AC02 - salbutamol : Belongs to the class of adrenergic inhalants, selective beta-2-adrenoreceptor agonists. Used in the treatment of obstructive airway diseases.
R03CC02 - salbutamol : Belongs to the class of adrenergics for systemic use, selective beta-2-adrenoreceptor agonists. Used in the treatment of obstructive airway diseases.
R03CC02 - salbutamol : Belongs to the class of adrenergics for systemic use, selective beta-2-adrenoreceptor agonists. Used in the treatment of obstructive airway diseases.
C09DB06 - losartan and amlodipine : Belongs to the class of angiotensin II receptor blockers (ARBs) and calcium channel blockers. Used in the treatment of cardiovascular disease.
R05FA02 - opium derivatives and expectorants : Belongs to the class of combinations of opium derivatives cough suppressants and expectorants. Used in the treatment of cough.
A02BA53 - famotidine, combinations : Belongs to the class of H2-receptor antagonists. Used in the treatment of peptic ulcer and gastro-oesophageal reflux disease (GERD).
M01AB15 - ketorolac : Belongs to the class of acetic acid derivatives and related substances of non-steroidal antiinflammatory and antirheumatic products.
M01AB15 - ketorolac : Belongs to the class of acetic acid derivatives and related substances of non-steroidal antiinflammatory and antirheumatic products.
P01AB01 - metronidazole : Belongs to the class of nitroimidazole derivatives antiprotozoals. Used in the treatment amoebiasis and other protozoal diseases.
P01AB01 - metronidazole : Belongs to the class of nitroimidazole derivatives antiprotozoals. Used in the treatment amoebiasis and other protozoal diseases.
C09DA01 - losartan and diuretics : Belongs to the class of angiotensin II receptor blockers (ARBs) in combination with diuretics. Used in the treatment of cardiovascular disease.
C09DA01 - losartan and diuretics : Belongs to the class of angiotensin II receptor blockers (ARBs) in combination with diuretics. Used in the treatment of cardiovascular disease.
A02BC01 - omeprazole : Belongs to the class of proton pump inhibitors. Used in the treatment of peptic ulcer and gastro-oesophageal reflux disease (GERD).
(vial + 10 mL amp diluent) 10 mL x 1's (P380.00/vial)
MIMS Class
Antacids, Antireflux Agents & Antiulcerants
ATC Classification
A02BC01 - omeprazole : Belongs to the class of proton pump inhibitors. Used in the treatment of peptic ulcer and gastro-oesophageal reflux disease (GERD).
J01EE01 - sulfamethoxazole and trimethoprim : Belongs to the class of combinations of sulfonamides and trimethoprim, including derivatives. Used in the systemic treatment of infections.
J01EE01 - sulfamethoxazole and trimethoprim : Belongs to the class of combinations of sulfonamides and trimethoprim, including derivatives. Used in the systemic treatment of infections.
J01EE01 - sulfamethoxazole and trimethoprim : Belongs to the class of combinations of sulfonamides and trimethoprim, including derivatives. Used in the systemic treatment of infections.
J01EE01 - sulfamethoxazole and trimethoprim : Belongs to the class of combinations of sulfonamides and trimethoprim, including derivatives. Used in the systemic treatment of infections.
C09DB04 - telmisartan and amlodipine : Belongs to the class of angiotensin II receptor blockers (ARBs) and calcium channel blockers. Used in the treatment of cardiovascular disease.
G01AA10, J01FF01 - clindamycin, clindamycin : Belongs to the class of antibiotics. Used in the treatment of gynecological infections., Belongs to the class of lincosamides. Used in the systemic treatment of infections.
J01CR02 - amoxicillin and beta-lactamase inhibitor : Belongs to the class of penicillin combinations, including beta-lactamase inhibitors. Used in the systemic treatment of infections.
J01CR02 - amoxicillin and beta-lactamase inhibitor : Belongs to the class of penicillin combinations, including beta-lactamase inhibitors. Used in the systemic treatment of infections.
J01CR02 - amoxicillin and beta-lactamase inhibitor : Belongs to the class of penicillin combinations, including beta-lactamase inhibitors. Used in the systemic treatment of infections.
J01CR02 - amoxicillin and beta-lactamase inhibitor : Belongs to the class of penicillin combinations, including beta-lactamase inhibitors. Used in the systemic treatment of infections.
J01CR02 - amoxicillin and beta-lactamase inhibitor : Belongs to the class of penicillin combinations, including beta-lactamase inhibitors. Used in the systemic treatment of infections.
J01CR02 - amoxicillin and beta-lactamase inhibitor : Belongs to the class of penicillin combinations, including beta-lactamase inhibitors. Used in the systemic treatment of infections.
J01CR02 - amoxicillin and beta-lactamase inhibitor : Belongs to the class of penicillin combinations, including beta-lactamase inhibitors. Used in the systemic treatment of infections.
J01CR02 - amoxicillin and beta-lactamase inhibitor : Belongs to the class of penicillin combinations, including beta-lactamase inhibitors. Used in the systemic treatment of infections.